154 related articles for article (PubMed ID: 22015859)
1. Bupropion in the treatment of major depressive disorder in real-life practice.
Sennfelt DA; Marques da Silva MA; Tavares AP
Clin Drug Investig; 2011 Oct; 31 Suppl 1():19-24. PubMed ID: 22015859
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and tolerability of bupropion in the treatment of major depressive disorder.
Moreira R
Clin Drug Investig; 2011 Oct; 31 Suppl 1():5-17. PubMed ID: 22015858
[TBL] [Abstract][Full Text] [Related]
3. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
Leuchter AF; Lesser IM; Trivedi MH; Rush AJ; Morris DW; Warden D; Fava M; Wisniewski SR; Luther JF; Perales M; Gaynes BN; Stewart JW
J Psychiatr Pract; 2008 Sep; 14(5):271-80. PubMed ID: 18832958
[TBL] [Abstract][Full Text] [Related]
4. Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study.
Jefferson JW; Rush AJ; Nelson JC; VanMeter SA; Krishen A; Hampton KD; Wightman DS; Modell JG
J Clin Psychiatry; 2006 Jun; 67(6):865-73. PubMed ID: 16848645
[TBL] [Abstract][Full Text] [Related]
5. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
Pae CU; Lim HK; Han C; Patkar AA; Steffens DC; Masand PS; Lee C
Expert Rev Neurother; 2007 Oct; 7(10):1251-63. PubMed ID: 17939764
[TBL] [Abstract][Full Text] [Related]
6. Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union.
Cooper JA; Tucker VL; Papakostas GI
J Psychopharmacol; 2014 Feb; 28(2):118-24. PubMed ID: 24352716
[TBL] [Abstract][Full Text] [Related]
7. Switching to bupropion in fluoxetine-resistant major depressive disorder.
Fava M; Papakostas GI; Petersen T; Mahal Y; Quitkin F; Stewart J; McGrath P
Ann Clin Psychiatry; 2003 Mar; 15(1):17-22. PubMed ID: 12839429
[TBL] [Abstract][Full Text] [Related]
8. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions.
Papakostas GI; Kornstein SG; Clayton AH; Soares CN; Hallett LA; Krishen A; Tucker VL
Int Clin Psychopharmacol; 2007 Jul; 22(4):226-9. PubMed ID: 17519646
[TBL] [Abstract][Full Text] [Related]
9. Killing two birds with one stone: the potential role of aripiprazole for patients with comorbid major depressive disorder and nicotine dependence via altering brain activity in the anterior cingulate cortex.
Chu CS; Tzeng NS; Chang HA; Chang CC; Chen TY
Med Hypotheses; 2014 Sep; 83(3):407-9. PubMed ID: 25109873
[TBL] [Abstract][Full Text] [Related]
10. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
Jefferson JW; Pradko JF; Muir KT
Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of depression in a Parkinson disease patient with bupropion].
Leentjens AF; Verhey FR; Vreeling FW
Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2157-9. PubMed ID: 11086491
[TBL] [Abstract][Full Text] [Related]
12. Bupropion (Zyban) for smoking cessation.
MacConnachie AM
Intensive Crit Care Nurs; 2000 Aug; 16(4):266-7. PubMed ID: 10922191
[No Abstract] [Full Text] [Related]
13. Psychopharmacology of smoking cessation in patients with mental illness.
Selby P
J Psychiatry Neurosci; 2006 Sep; 31(5):360. PubMed ID: 16951737
[No Abstract] [Full Text] [Related]
14. Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
Papakostas GI; Nutt DJ; Hallett LA; Tucker VL; Krishen A; Fava M
Biol Psychiatry; 2006 Dec; 60(12):1350-5. PubMed ID: 16934768
[TBL] [Abstract][Full Text] [Related]
15. Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?
Clayton AH
Expert Opin Pharmacother; 2007 Mar; 8(4):457-66. PubMed ID: 17309340
[TBL] [Abstract][Full Text] [Related]
16. [Bupropion. An antidepressant used to help smoking cessation].
Taeron C
Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615
[No Abstract] [Full Text] [Related]
17. Symptoms of fatigue and sleepiness in major depressive disorder.
Baldwin DS; Papakostas GI
J Clin Psychiatry; 2006; 67 Suppl 6():9-15. PubMed ID: 16848671
[TBL] [Abstract][Full Text] [Related]
18. [Antidepressive pharmacotherapy: changing paradigms].
Bánki MC
Neuropsychopharmacol Hung; 2004 Mar; 6(1):1-3. PubMed ID: 15125307
[No Abstract] [Full Text] [Related]
19. Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.
Paslakis G; Gilles M; Deuschle M
J Clin Psychopharmacol; 2010 Aug; 30(4):473-4. PubMed ID: 20631572
[No Abstract] [Full Text] [Related]
20. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].
Szabó Z; Argyelán M; Kanyó B; Pávics L; Janka Z
Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
